YAP‐LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine

Documenti analoghi

• ENO1 contributes to the gemcitabine resistance of pancreatic cancer through the YAP1 signaling pathway
  di: Hongqin Ma, et al.
  Pubblicazione: (2024)
• Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling
  di: Qun Chen, et al.
  Pubblicazione: (2024)
• Cancer‐associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF‐1α/miR‐21 axis under hypoxic conditions in pancreatic cancer
  di: Keping Deng, et al.
  Pubblicazione: (2024)
• Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy
  di: Xing Ma, et al.
  Pubblicazione: (2024)
• Corrigendum to “Nexrutine inhibits azoxymethane‐induced colonic aberrant crypt formation in rat colon and induced apoptotic cell death in colon adenocarcinoma cells”
  Pubblicazione: (2024)